{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-021265","form_type":"8-K","ticker":"GNLX","cik":"0001231457","company_name":"GENELUX Corp","filed_at":"2024-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.618051+00:00","generated_at":"2026-06-01T08:36:41.280905+00:00","sec_items":["1.01","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Genelux prices $27.5M offering of 6.875M shares and warrants at $4.00","bullets":["Gross proceeds ~$27.5M; net ~$25.4M from 6,875,000 shares and 6,875,000 warrants at combined $4.00/unit.","Each warrant exercisable at $5.25, immediately exercisable, expires 5 years from issuance.","Underwriters granted 30-day option for additional 1,031,250 shares and warrants (15% over-allotment).","Proceeds to fund working capital into Q1 2026 and Olvi-Vec development; Phase 3 OnPrime topline expected H2 2025.","Closing expected May 29, 2024; Guggenheim Securities sole bookrunner, Newbridge Securities co-manager."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-021265","json":"https://secwatch.observer/filing/0001493152-24-021265.json","markdown":"https://secwatch.observer/filing/0001493152-24-021265.md","text":"https://secwatch.observer/filing/0001493152-24-021265.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1231457/000149315224021265/0001493152-24-021265-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1231457/000149315224021265/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T08:36:41.280905+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}